Title:
患者においてタンパク質漏出性腸症を処置するための抗Ｃ５抗体の投薬量および投与
Document Type and Number:
Japanese Patent JP7194698
Kind Code:
B2
Abstract:
Provided are methods for clinical treatment of a protein-losing enteropathy, such as lymphangiectasia, using an anti-C5 antibody, or antigen binding fragment thereof, in patients (e.g., pediatric patients).
Inventors:
Adib, Ollie Eshak
Bedrosyan, Camille
Feldman, Hajit Barris
croup, arena
McKnight, Susan Firth
Bedrosyan, Camille
Feldman, Hajit Barris
croup, arena
McKnight, Susan Firth
Application Number:
JP2019563123A
Publication Date:
December 22, 2022
Filing Date:
May 21, 2018
Export Citation:
Assignee:
Alexion Pharmaceuticals, Incorporated
International Classes:
A61K39/395; A61P1/04; A61P7/00; A61P9/00
Domestic Patent References:
| JP2012508262A |
Foreign References:
| WO2018053039A1 |
Other References:
J. Immunol. (May 2017) vol.198, issue 1, Supplement, Abstract 59.10,
Nephrol. Dial. Transplant. (Feb 2017) vol.32, issue 3, p.466-474
Ann. Hematol. (2009) vol.88, issue7, p.705-707
Gut (1984) vol.25, issue 9, p.1013-1015
Nephrol. Dial. Transplant. (Feb 2017) vol.32, issue 3, p.466-474
Ann. Hematol. (2009) vol.88, issue7, p.705-707
Gut (1984) vol.25, issue 9, p.1013-1015
Attorney, Agent or Firm:
Shusaku Yamamoto
Morishita Natsuki
Morishita Natsuki
Previous Patent: Spacing combs and hair cutting tools
Next Patent: DEVICE FOR MONITORING PRESENCE OR ABSENCE OF FLUID IN PIPE
Next Patent: DEVICE FOR MONITORING PRESENCE OR ABSENCE OF FLUID IN PIPE